上海荣泰健康科技股份有限公司关于“荣泰转债”转股数量累计达到转股前公司已发行股份总额10%暨股份变动公告

Core Viewpoint - The announcement details the cumulative conversion of "Rongtai Convertible Bonds" into the company's common stock, indicating significant shareholder engagement and adjustments in conversion prices due to profit distribution plans [2][4][5][6][7][8]. Group 1: Convertible Bond Conversion Status - As of August 18, 2025, a total of RMB 338,153,000 worth of "Rongtai Convertible Bonds" has been converted into 14,654,387 shares, representing 10.4674% of the company's total shares before conversion [2][8]. - The remaining unconverted "Rongtai Convertible Bonds" amount to RMB 261,847,000, which is 43.6412% of the total issuance [2][8]. Group 2: Convertible Bond Issuance Overview - The company issued 6 million convertible bonds on October 30, 2020, with a total value of RMB 60 million and a maturity of 6 years, featuring a tiered interest rate structure [3]. - The bonds were listed on the Shanghai Stock Exchange on November 20, 2020, under the name "Rongtai Convertible Bonds" with the code "113606" [3]. Group 3: Conversion Price Adjustments - The initial conversion price was set at RMB 33.32 per share, which has been adjusted multiple times due to annual profit distribution plans, with the latest adjustment reducing the price to RMB 23.07 per share effective June 12, 2025 [4][5][6][7].